NICE COVID Guidelines Summary – Guidelines on Managing COVID-19 (2025) Updates in Medicine

Description

A summary of the 2025 updates to the NICE guidelines for managing COVID-19. It details current pharmacological recommendations, including the use of Nirmatrelvir + Ritonavir as the first-line antiviral, and notes the discontinuation of older treatments like Remdesivir and various monoclonal antibodies due to reduced efficacy against circulating variants.